keyword
Keywords Angiotensin receptor blockers ...

Angiotensin receptor blockers for pain

https://read.qxmd.com/read/38555468/development-and-validation-of-a-prognostic-model-for-predicting-post-discharge-mortality-risk-in-patients-with-st-segment-elevation-myocardial-infarction-stemi-undergoing-primary-percutaneous-coronary-intervention-ppci
#1
JOURNAL ARTICLE
Lingling Zhang, Zhican Liu, Yunlong Zhu, Mingxin Wu, Haobo Huang, Wenbin Yang, Ke Peng, Jianping Zeng
BACKGROUND: Accurately predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains a complex and critical challenge. The primary objective of this study was to develop and validate a robust risk prediction model to assess the 12-month and 24-month mortality risk in STEMI patients after hospital discharge. METHODS: A retrospective study was conducted on 664 STEMI patients who underwent PPCI at Xiangtan Central Hospital Chest Pain Center between 2020 and 2022...
March 30, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38465080/renal-infarction-as-the-first-manifestation-of-undiagnosed-atrial-fibrillation-with-coexisting-left-atrial-thrombus-a-case-report-and-review-of-the-literature
#2
Ahmad Damlakhy, Khaled M Harmouch, Zohaib A Khan, Nomesh Kumar, Anas Abdel-Qader
Acute renal infarction, presenting with nonspecific symptoms, such as abdominal pain, nausea, vomiting, and hematuria, can lead to delayed diagnosis due to similarities with other medical conditions. Computed tomography with IV contrast is used to diagnose renal parenchymal infarction, treated through surgical, percutaneous interventions, and anticoagulation therapy. Investigation for the infarction source is crucial, particularly in the absence of prior cardiac issues, necessitating heart rhythm monitoring and an echocardiogram to evaluate paroxysmal atrial fibrillation (PAF) and intracardiac thrombus, respectively...
February 2024: Curēus
https://read.qxmd.com/read/38428487/the-association-between-losartan-potassium-prescription-and-postoperative-outcomes-following-total-knee-arthroplasty-a-trinetx-analysis
#3
JOURNAL ARTICLE
Parimal Rana, Jane Brennan, Andrea Johnson, Justin Turcotte, James H MacDonald, Paul King
BACKGROUND: Total knee arthroplasty (TKA) is a common surgical procedure performed to alleviate pain and improve functional outcomes in patients with knee osteoarthritis and rheumatoid arthritis who have failed conservative treatments. Arthrofibrosis has been extensively studied due to its negative impact on TKA outcomes. Losartan, an angiotensin receptor blocker (ARB), has the potential to improve TKA outcomes by inhibiting TGF-β and decreasing fibrosis. This study aims to analyze a large-scale, real-world healthcare database to investigate the association between losartan potassium prescription and postoperative outcomes such as readmissions, ED visits, and the need for MUA or revision TKA...
February 28, 2024: Orthopaedics & Traumatology, Surgery & Research: OTSR
https://read.qxmd.com/read/38293826/transcriptomic-profiling-reveals-a-pronociceptive-role-for-angiotensin-ii-in-inflammatory-bowel-disease
#4
JOURNAL ARTICLE
James P Higham, Charity N Bhebhe, Rohit A Gupta, Michael M Tranter, Farah M Barakat, Harween Dogra, Natalie Bab, Eva Wozniak, Katie H Barker, Catherine H Wilson, Charles A Mein, Tim Raine, James J Cox, John N Wood, Nicholas M Croft, Paul D Wright, David C Bulmer
Visceral pain is a leading cause of morbidity in inflammatory bowel disease (IBD), contributing significantly to reduced quality of life. Currently available analgesics often lack efficacy or have intolerable side effects, driving the need for a more complete understanding of the mechanisms causing pain. Whole transcriptome gene expression analysis was performed by bulk RNA sequencing of colonic biopsies from patients with ulcerative colitis (UC) and Crohn disease (CD) reporting abdominal pain and compared with noninflamed control biopsies...
January 29, 2024: Pain
https://read.qxmd.com/read/38200077/clinical-and-preclinical-evidence-that-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-prevent-diabetic-peripheral-neuropathy
#5
JOURNAL ARTICLE
Shiori Iwane, Wataru Nemoto, Tomoyoshi Miyamoto, Tomonori Hayashi, Masayuki Tanaka, Kazuki Uchitani, Tatsuya Muranaka, Masanori Fujitani, Yuichi Koizumi, Atsushi Hirata, Maho Tsubota, Fumiko Sekiguchi, Koichi Tan-No, Atsufumi Kawabata
Given possible involvement of the central and peripheral angiotensin system in pain processing, we conducted clinical and preclinical studies to test whether pharmacological inhibition of the angiotensin system would prevent diabetic peripheral neuropathy (DPN) accompanying type 2 diabetes mellitus (T2DM). In the preclinical study, the nociceptive sensitivity was determined in leptin-deficient ob/ob mice, a T2DM model. A clinical retrospective cohort study was conducted, using the medical records of T2DM patients receiving antihypertensives at three hospitals for nearly a decade...
January 10, 2024: Scientific Reports
https://read.qxmd.com/read/38199739/a-39-year-old-man-with-refractory-chronic-cough-accompanied-by-regurgitation-and-belching
#6
Xu Shi, Shuxin Zhong, Mingyu Zhong, Songfeng Chen, Jing Li, Yinglian Xiao, Ruchong Chen
A 39-year-old man who did not smoke was admitted to the hospital with recurrent cough for 1 year, accompanied by sputum expectoration (with a small amount of white phlegm), acid regurgitation, and belching. Nasal symptoms or other cough-related contributing factors were denied. The patient reported that his cough mainly occurred at nighttime and was aggravated in the supine position. Vomiting could occur when the cough was violent. He denied fever, dysphonia, chest tightness, wheezing, chest pain and hemoptysis, abdominal pain, and bloating...
January 2024: Chest
https://read.qxmd.com/read/38169588/marked-hepatotoxicity-associated-with-losartan-treatment-a-case-report
#7
Iman Zahedi, Mohamed Sami, Olumide Ijishakin, Henry Onyemarim, Riyotta T Cutliff, Victor C Ezeamii
Losartan is a widely prescribed angiotensin II receptor blocker (ARB) used for the management of hypertension and various cardiovascular conditions. While it is generally considered a safe medication, rare cases of hepatotoxicity have been reported in the literature. We present a case of severe hepatic injury and sub-fulminant hepatitis attributed to losartan use in a 54-year-old male patient with underlying hypertension. He presented with a two-week history of abdominal pain, progressive jaundice, dark urine, and vomiting, followed by altered sensorium...
December 2023: Curēus
https://read.qxmd.com/read/38035129/trends-of-antihypertensive-antidiabetic-and-nonsteroidal-anti-inflammatory-drugs-use-among-the-health-workers-cohort-study-mexico-2004-to-2018
#8
JOURNAL ARTICLE
Janinne Ortega-Montiel, Alejandra Montoya, René Soria-Saucedo, Katia Gallegos-Carrillo, Paula Ramírez-Palacios, Jorge Salmerón, Eduardo Salazar-Martínez
BACKGROUND: Hypertension and type 2 diabetes (T2D) are the most prevalent noncommunicable diseases in Mexico and worldwide. According to international practice management guidelines, the principal chronic management therapy is daily oral medication. AIM: We aim to describe the trends of antihypertensive, antidiabetic, and nonsteroidal anti-inflammatory (NSAID) drugs use among the Mexican adult population from 2004-2018. METHODS: We analyzed data from the Health Workers Cohort Study (HWCS) for males and females aged >18 years...
2023: Advances in pharmacological and pharmaceutical sciences
https://read.qxmd.com/read/37995049/patient-reported-reasons-for-antihypertensive-medication-change-a-quantitative-study-using-social-media
#9
JOURNAL ARTICLE
Cristina Micale, Su Golder, Karen O'Connor, Davy Weissenbacher, Robert Gross, Sean Hennessy, Graciela Gonzalez-Hernandez
INTRODUCTION: Hypertension is the leading cause of heart disease in the world, and discontinuation or nonadherence of antihypertensive medication constitutes a significant global health concern. Patients with hypertension have high rates of medication nonadherence. Studies of reasons for nonadherence using traditional surveys are limited, can be expensive, and suffer from response, white-coat, and recall biases. Mining relevant posts by patients on social media is inexpensive and less impacted by the pressures and biases of formal surveys, which may provide direct insights into factors that lead to non-compliance with antihypertensive medication...
November 23, 2023: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
https://read.qxmd.com/read/37736595/valproate-induced-burning-mouth-syndrome-in-a-male-with-fibromyalgia-and-bipolar-spectrum-disorder
#10
Accursio Raia, Valerio Caruso, Clara Montalbano, Lavinia Migli, Calogero Raia, Stefano Pini
Burning mouth syndrome is a chronic painful condition characterized by a subjective intraoral pain and burning sensations in the absence of an identifiable medical, dental, or psychiatric cause. Although the underlying etiology is currently unclear, an idiopathic (or primary) form and a secondary form to other conditions are formally recognized. However, as several authors have suggested, it might be of clinical utility to consider the existence of a third clinical entity, namely Drug-Induced Burning mouth syndrome, for its therapeutic implications...
2023: Archive of clinical cases
https://read.qxmd.com/read/37640625/rationale-and-design-of-the-aramis-trial-anakinra-versus-placebo-a-double-blind-randomized-controlled-trial-for-the-treatment-of-acute-myocarditis
#11
JOURNAL ARTICLE
Mathieu Kerneis, Fleur Cohen, Alain Combes, Zahir Amoura, Carine Pare, Delphine Brugier, Etienne Puymirat, Jeremie Abtan, Benoit Lattuca, Jean-Guillaume Dillinger, Marie Hauguel-Moreau, Johanne Silvain, Joe-Elie Salem, Estelle Gandjbakhch, Guillaume Hekimian, Alban Redheuil, Eric Vicaut, Gilles Montalescot
BACKGROUND: Acute myocarditis is an inflammation of the myocardium that can cause life-threatening events. However, anti-inflammatory strategies did not reduce the risk of clinical outcomes in randomized trials. Recently, experimental studies have suggested that specific blockade of the interleukin-1β immune innate pathway could be effective in acute myocarditis. AIM: To test the hypothesis that inhibition of the interleukin-1β immune innate pathway can reduce the risk of clinical events in acute myocarditis...
August 12, 2023: Archives of Cardiovascular Diseases
https://read.qxmd.com/read/37559845/a-rare-case-of-olmesartan-associated-enteropathy-successfully-managed-with-steroid-taper
#12
Angela Xue, Mark R Fowler, Jan Silverman, Emily Sturkie, Evan Raff
Olmesartan is a commonly used antihypertensive medication belonging to the class of angiotensin II receptor blockers. Though generally well-tolerated, olmesartan can rarely cause olmesartan-associated enteropathy (OAE) with non-bloody diarrhea, weight loss, abdominal pain, and vomiting. Patients may develop enteropathy months to years after drug initiation. In severe cases, patients may develop complications that require hospitalization. Diagnosis is often delayed due to unfamiliarity of OAE, nonspecific presenting symptoms, and normal-appearing gross endoscopic findings...
July 2023: Curēus
https://read.qxmd.com/read/37545028/changes-in-process-and-outcome-for-st-elevation-myocardial-infarction-in-central-china-from-2011-to-2018
#13
JOURNAL ARTICLE
You Zhang, Shan Wang, Datun Qi, Xianpei Wang, Muwei Li, Zhongyu Zhu, Qianqian Cheng, Dayi Hu, Chuanyu Gao
BACKGROUND: Limited data are available on the changes in the quality of care for ST elevation myocardial infarction (STEMI) during China's health system reform from 2009 to 2020. We aimed to assess the changes in care processes and outcome for STEMI patients in Henan province of central China between 2011 and 2018. METHODS: We compared the data from the Henan STEMI survey conducted in 2011-2012 (n = 1548, a cross-sectional study) and the Henan STEMI registry in 2016-2018 (n = 4748, a multicenter, prospective observational study)...
August 4, 2023: Chinese Medical Journal
https://read.qxmd.com/read/37421264/trigger-associated-clinical-implications-and-outcomes-in-takotsubo-syndrome-results-from-the-multicenter-geist-registry
#14
JOURNAL ARTICLE
Toni Pätz, Francesco Santoro, Rosa Cetera, Ilaria Ragnatela, Ibrahim El-Battrawy, Matthias Mezger, Elias Rawish, Mireia Andrés-Villarreal, Manuel Almendro-Delia, Manuel Martinez-Sellés, Aitor Uribarri, Alberto Pérez-Castellanos, Federico Guerra, Giuseppina Novo, Enrica Mariano, Maria Beatrice Musumeci, Luca Arcari, Luca Cacciotti, Roberta Montisci, Ibrahim Akin, Holger Thiele, Natale Daniele Brunetti, Oscar Vedia, Ivan J Núñez-Gil, Ingo Eitel, Thomas Stiermaier
Background Takotsubo syndrome is usually triggered by a stressful event. The type of trigger seems to influence the outcome and should therefore be considered separately. Methods and Results Patients included in the GEIST (German-Italian-Spanish Takotsubo) registry were categorized according to physical trigger (PT), emotional trigger (ET), and no trigger (NT) of Takotsubo syndrome. Clinical characteristics as well as outcome predictors were analyzed. Overall, 2482 patients were included. ET was detected in 910 patients (36...
July 8, 2023: Journal of the American Heart Association
https://read.qxmd.com/read/37336337/isolation-of-alkaloidal-and-glycosidal-fractions-from-leaves-of-trigonella-foenum-graecum-l-cv-desi-indigenous-to-pakistan-for-antiprostaglandin-evaluation-as-substitute-of-nonsteroidal-anti-inflammatory-drugs
#15
JOURNAL ARTICLE
Tahir Mahmood Shaukat, Muhammad Ovais Omer, Aqeel Javeed, Habib Ur Rehman, Tariq Mahmood Shaukat
ETHNOPHARMACOLOGICAL RELEVANCE: Trigonella foenum graecum (fenugreek) has been in use for a long time as a traditional medicine and natural food additive. The reported gastro-protective property makes it unique among other herbs. Seeds and leaves have been shown to exert significant antiatherogenic, antidiabetic, antianorexic, antioxidant, anticarcinogenic, antihyperlipidemic, galactogogue and anti-inflammatory effects in several animal and human models. But its use as a substitute for ulcerative nonsteroidal anti-inflammatory drugs needs to be confirmed...
June 17, 2023: Journal of Ethnopharmacology
https://read.qxmd.com/read/37175678/telmisartan-is-a-promising-agent-for-managing-neuropathic-pain-and-delaying-opioid-analgesic-tolerance-in-rats
#16
JOURNAL ARTICLE
David Á Karádi, Anna Rita Galambos, Péter P Lakatos, Joost Apenberg, Sarah K Abbood, Mihály Balogh, Kornél Király, Pál Riba, Nariman Essmat, Edina Szűcs, Sándor Benyhe, Zoltán V Varga, Éva Szökő, Tamás Tábi, Mahmoud Al-Khrasani
Despite the large arsenal of analgesic medications, neuropathic pain (NP) management is not solved yet. Angiotensin II receptor type 1 (AT1) has been identified as a potential target in NP therapy. Here, we investigate the antiallodynic effect of AT1 blockers telmisartan and losartan, and particularly their combination with morphine on rat mononeuropathic pain following acute or chronic oral administration. The impact of telmisartan on morphine analgesic tolerance was also assessed using the rat tail-flick assay...
April 27, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37101993/olmesartan-induced-ischemic-enteritis-complicated-with-bowel-perforation-a-case-report-and-literature-review
#17
Dheeraj Alexander, Basel Abdelazeem, Mustafa Alnounou
Olmesartan is a relatively new angiotensin receptor blocker used widely to control hypertension. Cases have been reported previously of enteropathy induced by olmesartan. Here, the authors report a case of olmesartan-induced ischemic enteritis complicated by bowel perforation. A 52-year-old male patient, during the treatment with olmesartan, developed severe abdominal pain of five-day duration. He underwent exploratory laparotomy for bowel perforation and surgical resection of the ischemic bowel segment. On a two-month follow-up after the discontinuation of olmesartan and the emergency surgery, the patient was symptom-free and functioning well...
March 2023: Curēus
https://read.qxmd.com/read/36841792/risk-factors-of-preoperative-myocardial-injury-in-patients-with-gastrointestinal-tumors
#18
JOURNAL ARTICLE
Shuqi Yu, Shiyao Cheng, Jinhong Si, Huajing Peng, Jiachen Wan, Jiaojie Xue, Zhichong Chen, Sutian Hu, Ling Zhou, Yitao Zhang, Weijie Zeng
BACKGROUND: Recent studies indicated that the prognosis of patients with gastrointestinal tumors is frequently influenced by its complications, notably myocardial injury. The main object is to investigate the occurrence and risk factors of myocardial injury in patients with gastrointestinal tumor. METHODS: 1126 patients who received gastrointestinal tumor related surgery from May 2018 to June 2020 in the Sixth Affiliated Hospital of Sun Yat-sen University were retrospectively collected and divided into the non-myocardial injury group and the myocardial injury group (high-sensitive cardiac troponin I (hs-cTnI) ≥ 0...
February 25, 2023: BMC Cardiovascular Disorders
https://read.qxmd.com/read/36613755/role-of-renin-angiotensin-aldosterone-system-and-cortisol-in-endometriosis-a-preliminary-report
#19
JOURNAL ARTICLE
Chiara Sabbadin, Carlo Saccardi, Alessandra Andrisani, Amerigo Vitagliano, Loris Marin, Eugenio Ragazzi, Luciana Bordin, Guido Ambrosini, Decio Armanini
Endometriosis is a chronic inflammatory disease associated with pelvic pain, infertility, and increased cardiovascular risk. Recent studies suggest a possible role of aldosterone as a pro-inflammatory hormone in the pathogenesis of the disease. Cortisol is also an important mediator of stress reaction, but its role is controversial in endometriosis. The aim of this study was to evaluate aldosterone and cortisol levels and blood pressure values in women with endometriosis. We measured blood pressure, plasma aldosterone, renin, cortisol, and dehydroepiandrosterone sulfate (DHEAS) in 20 women with untreated minimal or mild pelvic endometriosis compared with 20 healthy controls matched for age and body mass index...
December 24, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36475528/intradermal-delivery-of-an-angiotensin-ii-receptor-blocker-using-a-personalized-microneedle-patch-for-treatment-of-hypertrophic-scars
#20
JOURNAL ARTICLE
Yihui Huang, Jingwen Li, Yan Wang, Danyang Chen, Jianglong Huang, Wubin Dai, Pan Peng, Liang Guo, Yifeng Lei
High-quality postoperative rehabilitation is the focus of most patients currently, and hypertrophic scar (HS) greatly reduces the patient's quality of life due to the symptom of severe itching. Traditional HS therapies are associated with limitations, such as poor drug delivery efficiency for topical administration and severe pain for intralesional injection. In this study, we developed a personalized microneedle patch system for minimally invasive and effective treatment of HSs. The microneedle patches were personalized designed and fabricated with 3D printing in order to adapt to individual HS...
January 17, 2023: Biomaterials Science
keyword
keyword
107089
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.